Ankylosing spondylitis (AS) | sciencenewsnet.in

Breaking News

KSTAR Embarks on 2024 Plasma Experiments to Advance Fusion Reactor Operations

Thai Language Courses for Foreign Nationals at Chula

Refining hardwood by bioluminescence

Commercialization of Korea’s First 600mm Large-Area Semiconductor Packaging Technology with 6.5x Productivity Increase

Medicated nasal spray will slash opioid-related hospital admissions

Research highlights greater financial hardship and importance of the legal system for divorced survivors of domestic abuse

Are Health Care Disparities Tied to Worse Outcomes for Kids with MS?

For Those with CTE, Family History of Mental Illness Tied to Aggression in Middle Age

What a Second Trump Presidency Will Mean for Energy and Climate

Patient returns to Houston Methodist 20 years after lifesaving surgery

28 Nov, 2024

Study Finds Early TNF Inhibitor Treatment Is Associated with Higher Heart Disease Risk in Ankylosing Spondylitis Patients — with Caveats

November 8, 2022 sarah JonasResearch Results

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that early initiation of tumor necrosis factor (TNF) inhibitors was associated with higher risk of heart disease in patients diagnosed with ankylosing spondylitis.